Position in NYXH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,557,335
New position
Shares Held
921,500
first reported quarter
Ownership
0.905%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#3
of 45 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 100%
None 0%
Position in Medical Devices
Healthcare · as of Jun 30, 2026Blackstone Inc. holds $11,418,820 across 9 Medical Devices names. NYXH ranks #3 (13.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
124,174 | $5,299,746 | |
| 2 | PEN |
Penumbra Inc
|
5,407 | $1,707,260 | |
| 3 | NYXH |
Nyxoah SA
This page
|
921,500 | $1,557,335 | |
| 4 | AXGN |
Axogen, Inc.
|
15,461 | $714,143 | |
| 5 | HAE |
Haemonetics Corp
|
8,268 | $620,100 | |
| 6 | DXCM |
Dexcom Inc
|
7,909 | $532,671 | |
| 7 | STE |
STERIS plc
|
1,933 | $407,031 | |
| 8 | ZBH |
Zimmer Biomet Holdings, Inc.
|
3,552 | $305,791 |
All Filings in NYXH
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,557,335 | 921,500 | Shares | Other | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||